NCT05647109Recruiting
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
Department of Obstetrics & Gynecology ，Peking University People's Hospital
Source: ClinicalTrials.gov · Last updated 4 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To construct a prediction model of progesterone sensitivity in patients with endometrial cancer treated with fertility preservation
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 244 (estimated)
- First submitted
- 2 Dec 2022
- Start date
- 1 Sept 2021
- Primary completion date
- 31 Aug 2025
- Lead sponsor
- Peking University People's Hospital
- Diseases
- Endometrial cancer, Childhood cancers
- NCT number
- NCT05647109
What you commit to
- Study type: Observational
- Planned participants: 244
- From 1 Sept 2021 to the primary completion date, 31 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Acute liver disease or liver tumor (benign or malignant) or renal dysfunction
- Confirmed diagnosis of any cancer in reproductive system
- Acute severe disease such as stroke or heart infarction or a history of thrombosis disease
- Hypersensitivity or contradiction for using MPA or MA
Other
- Pregnancy or potential pregnancy
- With other factors of reproductive dysfunction;
- Strong request for uterine removal or other conservative treatment
Who the study is looking for
- Have a confirmed pathological diagnosis based upon hysteroscopy: atypical endometrial hyperplasia or histologically prove well-differentiated EEC G1 without myometrial invasion
- No signs of suspicious extrauterine involvement on enhanced magnetic resonance imaging (MRI) or enhanced computed tomography (CT) or ultrasound
- Have a desire for remaining reproductive function or uterus
- Good compliance with adjunctive treatment and follow-up
Age in the registry: 17 years to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.